首页> 外国专利> Primer set for CYP2C19 gene amplification, kit for CYP2C19 gene amplification, gene amplification method, polymorm analysis method, and drug efficacy determination method

Primer set for CYP2C19 gene amplification, kit for CYP2C19 gene amplification, gene amplification method, polymorm analysis method, and drug efficacy determination method

机译:用于CYP2C19基因扩增的引物组,用于CYP2C19基因扩增的试剂盒,基因扩增方法,多态性分析方法和药物功效确定方法

摘要

A primer set for CYP2C19*2 includes a forward primer consisting of a base sequence represented by SEQ ID NO:3, and a reverse primer consisting of a base sequence represented by SEQ ID NO:4. A primer set for CYP2C19*3 includes a forward primer consisting of a base sequence represented by SEQ ID NO:5, and a reverse primer consisting of a base sequence represented by SEQ ID NO:6. A primer set for CYP2C19*17 includes a forward primer consisting of a base sequence represented by SEQ ID NO:7, and a reverse primer consisting of a base sequence represented by SEQ ID NO:11. A primer set for CYP2C 19* 17 includes, for example, a forward primer consisting of a base sequence represented by SEQ ID NO:7, and a reverse primer that is an oligonucleotide consisting of a base sequence represented by SEQ ID NO:12.
机译:CYP2C19 * 2的引物组包括由SEQ ID NO:3表示的碱基序列组成的正向引物和由SEQ ID NO:4表示的碱基序列组成的反向引物。 CYP2C19 * 3的引物组包括由SEQ ID NO:5表示的碱基序列组成的正向引物和由SEQ ID NO:6表示的碱基序列组成的反向引物。 CYP2C19 * 17的引物组包括由SEQ ID NO:7表示的碱基序列组成的正向引物和由SEQ ID NO:11表示的碱基序列组成的反向引物。 CYP2C 19 * 17的引物组包括,例如,由SEQ ID NO:7表示的碱基序列组成的正向引物,和作为由SEQ ID NO:12表示的碱基序列组成的寡核苷酸的反向引物。

著录项

  • 公开/公告号JP6490990B2

    专利类型

  • 公开/公告日2019-03-27

    原文格式PDF

  • 申请/专利权人 アークレイ株式会社;

    申请/专利号JP20150043933

  • 发明设计人 田副 秀章;

    申请日2015-03-05

  • 分类号C12N15/11;C12Q1/6844;

  • 国家 JP

  • 入库时间 2022-08-21 12:19:26

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号